183 related articles for article (PubMed ID: 18037281)
1. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies.
Calon F; Cole G
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):287-93. PubMed ID: 18037281
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acids and dementia.
Cole GM; Ma QL; Frautschy SA
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):213-21. PubMed ID: 19523795
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic and Arachidonic Acids as Neuroprotective Nutrients throughout the Life Cycle.
Sambra V; Echeverria F; Valenzuela A; Chouinard-Watkins R; Valenzuela R
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33803760
[TBL] [Abstract][Full Text] [Related]
4. Curcumin and omega-3 polyunsaturated fatty acids as bioactive food components with synergistic effects on Alzheimer's disease.
Velasco-Rodríguez LDC; García HS; Rascón-Díaz MP
Psychogeriatrics; 2024 May; 24(3):701-718. PubMed ID: 38528391
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective and antioxidant effects of docosahexaenoic acid (DHA) in an experimental model of multiple sclerosis.
Muñoz-Jurado A; Escribano BM; Galván A; Valdelvira ME; Caballero-Villarraso J; Giraldo AI; Santamaría A; Luque E; Agüera E; LaTorre M; Túnez I
J Nutr Biochem; 2024 Feb; 124():109497. PubMed ID: 37875228
[TBL] [Abstract][Full Text] [Related]
6. Overview of alkyl quercetin lipophenol synthesis and its protective effect against carbonyl stress involved in neurodegeneration.
Otaegui L; Lehoux J; Martin L; Givalois L; Durand T; Desrumaux C; Crauste C
Org Biomol Chem; 2024 Apr; 22(14):2877-2890. PubMed ID: 38525805
[TBL] [Abstract][Full Text] [Related]
7. DHA may prevent age-related dementia.
Cole GM; Frautschy SA
J Nutr; 2010 Apr; 140(4):869-74. PubMed ID: 20181786
[TBL] [Abstract][Full Text] [Related]
8. The conceivable role of prolactin hormone in Parkinson disease: The same goal but with different ways.
Al-Kuraishy HM; Jabir MS; Al-Gareeb AI; Albuhadily AK
Ageing Res Rev; 2023 Nov; 91():102075. PubMed ID: 37714384
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.
Yurko-Mauro K; McCarthy D; Rom D; Nelson EB; Ryan AS; Blackwell A; Salem N; Stedman M;
Alzheimers Dement; 2010 Nov; 6(6):456-64. PubMed ID: 20434961
[TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemia.
Mayurasakorn K; Williams JJ; Ten VS; Deckelbaum RJ
Curr Opin Clin Nutr Metab Care; 2011 Mar; 14(2):158-67. PubMed ID: 21178607
[TBL] [Abstract][Full Text] [Related]
11. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
[TBL] [Abstract][Full Text] [Related]
12. Α-synuclein neuropathology is controlled by nuclear hormone receptors and enhanced by docosahexaenoic acid in a mouse model for Parkinson's disease.
Yakunin E; Loeb V; Kisos H; Biala Y; Yehuda S; Yaari Y; Selkoe DJ; Sharon R
Brain Pathol; 2012 May; 22(3):280-94. PubMed ID: 21929559
[TBL] [Abstract][Full Text] [Related]
13. Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease.
Bousquet M; Gue K; Emond V; Julien P; Kang JX; Cicchetti F; Calon F
J Lipid Res; 2011 Feb; 52(2):263-71. PubMed ID: 21115966
[TBL] [Abstract][Full Text] [Related]
14. Nervonic Acid Synthesis Substrates as Essential Components in Profiled Lipid Supplementation for More Effective Central Nervous System Regeneration.
Namiecinska M; Piatek P; Lewkowicz P
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612605
[TBL] [Abstract][Full Text] [Related]
15. Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration.
Álvarez-Córdoba M; Talaverón-Rey M; Povea-Cabello S; Cilleros-Holgado P; Gómez-Fernández D; Piñero-Pérez R; Reche-López D; Munuera-Cabeza M; Suárez-Carrillo A; Romero-González A; Romero-Domínguez JM; López-Cabrera A; Armengol JÁ; Sánchez-Alcázar JA
Pharmaceuticals (Basel); 2023 Sep; 16(10):. PubMed ID: 37895830
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 index as risk factor in psychiatric diseases: a narrative review.
Antao HS; Sacadura-Leite E; Bandarra NM; Figueira ML
Front Psychiatry; 2023; 14():1200403. PubMed ID: 37575565
[TBL] [Abstract][Full Text] [Related]
17. Towards early detection of neurodegenerative diseases: A gut feeling.
Makdissi S; Parsons BD; Di Cara F
Front Cell Dev Biol; 2023; 11():1087091. PubMed ID: 36824371
[TBL] [Abstract][Full Text] [Related]
18. Relationship between Nutrition, Lifestyle, and Neurodegenerative Disease: Lessons from
Barati S; Fabrizio C; Strafella C; Cascella R; Caputo V; Megalizzi D; Peconi C; Mela J; Colantoni L; Caltagirone C; Termine A; Giardina E
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011409
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels.
Álvarez-Córdoba M; Reche-López D; Cilleros-Holgado P; Talaverón-Rey M; Villalón-García I; Povea-Cabello S; Suárez-Rivero JM; Suárez-Carrillo A; Munuera-Cabeza M; Piñero-Pérez R; Sánchez-Alcázar JA
Orphanet J Rare Dis; 2022 Aug; 17(1):311. PubMed ID: 35945593
[TBL] [Abstract][Full Text] [Related]
20. Free Radical Chain Reactions and Polyunsaturated Fatty Acids in Brain Lipids.
Ng SCW; Furman R; Axelsen PH; Shchepinov MS
ACS Omega; 2022 Jul; 7(29):25337-25345. PubMed ID: 35910174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
